|
| |
|
ICR
Steering Committee |
|
| |
|
|
The ICR is an interactive group of laboratories
whose primary purpose is to supply investigators
with clinical grade islets for ICR-approved studies.
The Steering Committee (SC) will oversee the general
functions of the ICR, based on the present Policy
and Procedures document, and evaluate the clinical
and scientific merit of submitted applications.
The SC will also determine which ICR facility will
produce the islets for each ICR-approved request.
After distribution of the islets, the ICR SC will
become informed of, and will monitor, serious adverse
events involving ICR-supported protocols when the
clinical investigator reports them to local and
Federal oversight groups in accordance with institutional,
state, and Federal guidelines. The SC will not serve
as a Data and Safety Monitoring Board for individual
transplantation protocols.
The ICR Steering Committee
is comprised of the chairman, the Administrative
and Bioinformatics Coordinating Center (ABCC) Director,
10 ICR directors, 2 outside experts, a Food and
Drug Administration (FDA) representative, a National Institutes
of Diabetes and Digestive Kidney Diseases (NIDDK)
representative, a Juvenile Diabetes Research Foundation
International (JDRFI) representative, and a National
Center for Research Resources (NCRR) representative.
|
|
|
|
|
|